Sei Investments CO Revance Therapeutics, Inc. Transaction History

Sei Investments CO

$74.7 Billion
Q3 2024

A detailed history of Sei Investments CO transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Sei Investments CO holds 18,438 shares of RVNC stock, worth $47,385. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,438

Previous 22,167 16.82%

Holding current value

$47,385

Previous $56,000 16.07%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$2.57 - $2.57 $9,583 - $9,583	-3,729 Reduced 16.82%	18,438 $47,000
Q2 2024 Aug 13, 2024	BUY	$2.34 - $4.73 $17,849 - $36,080	7,628 Added 52.47%	22,167 $56,000
Q1 2024 May 07, 2024	SELL	$4.65 - $9.31 $233,643 - $467,790	-50,246 Reduced 77.56%	14,539 $71,000
Q4 2023 Feb 14, 2024	SELL	$5.81 - $11.2 $51,267 - $98,828	-8,824 Reduced 11.99%	64,785 $569,000
Q3 2023 Nov 14, 2023	SELL	$11.47 - $25.07 $2.26 Million - $4.95 Million	-197,470 Reduced 72.85%	73,609 $844,000
Q2 2023 Aug 11, 2023	SELL	$24.7 - $37.61 $372,278 - $566,857	-15,072 Reduced 5.27%	271,079 $6.86 Million
Q1 2023 May 12, 2023	BUY	$18.36 - $35.27 $2.1 Million - $4.03 Million	114,296 Added 66.51%	286,151 $9.22 Million
Q4 2022 Feb 10, 2023	BUY	$18.32 - $30.66 $298,396 - $499,390	16,288 Added 10.47%	171,855 $3.17 Million
Q3 2022 Nov 14, 2022	BUY	$14.33 - $28.47 $1.18 Million - $2.35 Million	82,590 Added 113.17%	155,567 $4.2 Million
Q2 2022 Aug 15, 2022	BUY	$11.52 - $20.4 $31,057 - $54,998	2,696 Added 3.84%	72,977 $1 Million
Q1 2022 May 13, 2022	SELL	$12.36 - $20.31 $32,704 - $53,740	-2,646 Reduced 3.63%	70,281 $1.37 Million
Q4 2021 Feb 14, 2022	BUY	$12.46 - $27.87 $2,791 - $6,242	224 Added 0.31%	72,927 $1.19 Million
Q3 2021 Nov 12, 2021	SELL	$25.78 - $33.21 $90,797 - $116,965	-3,522 Reduced 4.62%	72,703 $2.03 Million
Q2 2021 Aug 06, 2021	SELL	$26.8 - $31.84 $252,375 - $299,837	-9,417 Reduced 11.0%	76,225 $2.26 Million
Q1 2021 May 12, 2021	SELL	$24.03 - $29.97 $196,517 - $245,094	-8,178 Reduced 8.72%	85,642 $2.4 Million
Q4 2020 Feb 08, 2021	SELL	$23.41 - $28.34 $351,641 - $425,695	-15,021 Reduced 13.8%	93,820 $2.66 Million
Q3 2020 Dec 04, 2020	SELL	$23.23 - $34.3 $23,624 - $34,883	-1,017 Reduced 0.93%	108,841 $2.74 Million
Q3 2020 Nov 06, 2020	BUY	$23.23 - $34.3 $89,063 - $131,506	3,834 Added 3.62%	109,858 $2.77 Million
Q2 2020 Aug 17, 2020	SELL	$12.6 - $26.55 $67,888 - $143,051	-5,388 Reduced 4.84%	106,024 $2.59 Million
Q2 2020 Aug 11, 2020	BUY	$12.6 - $26.55 $62,760 - $132,245	4,981 Added 4.68%	111,412 $1.81 Million
Q1 2020 May 14, 2020	SELL	$12.46 - $27.81 $62,549 - $139,606	-5,020 Reduced 4.5%	106,431 $1.57 Million
Q4 2019 Feb 06, 2020	BUY	$11.66 - $20.15 $1.3 Million - $2.25 Million	111,451 New	111,451 $1.81 Million

Others Institutions Holding RVNC

# of Institutions

234

Shares Held

82.8M

Call Options Held

680K

Put Options Held

896K

View Full List

About Revance Therapeutics, Inc.

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

More about RVNC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account

Sei Investments CO Revance Therapeutics, Inc. Transaction History